Assessment of Mismatch Repair Gene Expression in Colorectal Carcinoma: A Two-Year Single-Center Study
DOI:
https://doi.org/10.46966/msjar.v7i3.426Keywords:
Colorectal carcinoma, Mismatch repair (MMR), Gene expression, Microsatellite instability (MSI), Immunohistochemistry, Biomarkers, Tumor pathologyAbstract
Background:Mismatch repair MMR deficiency is a crucial biomarker in colorectal carcinoma (CRC) with the diagnosis, prognosis, and treatment significance of the MMR deficiency. MMR deficiency testing has become universally recommended to allow for Lynch syndrome screening and for the identification of the candidates for immune checkpoint inhibitor therapy. This study aims to evaluate the incidence of MMR protein expression in Iraqi patients with colorectal carcinoma and study their association with clinicopathological parameters. Methods: The retrospective cross-sectional study consisted of 34 patients histopathologically confirmed with primary colorectal carcinoma and these patients underwent surgical resection between January 2024 to December 2025 in Al-Warith International Cancer Institute, Karbala, Iraq. The immunohistochemistry expression for MLH1, PMS2, MSH2, and MSH6 genes were assessed using formalin-fixed, paraffin-embedded tissue sections. The correlation between the MMR and clinicopathological factors was analyzed using Fisher’s exact test or Fisher-Freeman-Halton exact test, as appropriate. Results: dMMR protein expression was identified in 4 out of 34 patients (11.8%), whereas 30 out of 34 patients (88.2%) showed proficient MMR expression. The most frequent MMR protein deficiency pattern was the MLH1/PMS2 deficiency, while the second most frequent was the MSH2/MSH6 deficiency, and only 1 out of 34 patients had MSH6 deficiency alone. There was a statistically significant correlation between dMMR expression and the location of the tumor (P = 0.009) and tumor grade (P = 0.035). No correlation was found between MMR protein expression and age, sex, cancer staging, histological type or lymph node involvement. No statistically significant correlation was observed with age, sex, tumor staging, histological type, or lymph node involvement. Conclusion: The incidence of dMMR in the studied Iraqi population was comparable to that proposed in earlier regional and international studies. Despite the existence of a relationship between the site of the tumor and its grade, it is necessary to mention that these findings should be taken into account with reservation due to the small number of participants and need for further validation.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Rasha Abd AL Raouf AL Safi AL Safi, Sora Ali Hasan Alhzamat, Mohammed Fawzi, Shaima Jabbar

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















